Stephen P Juraschek, MD, PhD, FAHA, AHSCP-CHS

Apariciones en rankings

Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.

Esta cuenta aún no ha aparecido en un ranking diario.

Posts que le gustaron recientemente

Me gusta públicos de la red Bluesky.

• American Journal of Hypertension@amjhypertension.bsky.social02-10-2026 15:21

  #HotOffThePress Effects of Anti-Hypertensive Agents on Orthostatic Changes: Secondary Analysis of the Treatment of Mild Hypertension Study (TOMHS) academic.oup.com/ajh/advance-...

  Ver post
• Marwah Abdalla, MD MPH@marwahabdalla.bsky.social26-05-2026 17:17

  We have more ways to measure blood pressure than ever before but not necessarily more confidence in what those measurements mean. Our NHLBI workshop report in @jaccjournals.bsky.social chaired w/ @spjuraschek.bsky.social provides an implementation roadmap. www.sciencedirect.com/science/arti...

  Ver post
• Andrew Michael South, MD, MS@asouth-neph.bsky.social13-05-2026 00:27

  Terrific to learn from and work with you @spjuraschek.bsky.social and so many of the fantastic #Hypertension folks out there #BloodPressure #LifeSpan www.sciencedirect.com/science/arti...

  Ver post
• Alex Chang, MD@alexchangmd.bsky.social22-04-2026 18:50

  Interesting paper - Factors Associated With Discussing High Blood Pressure Readings in Clinical Notes. Naturally, nephrology, transplant, internal med are discussing the most (it's part of the job). ID, endocrine, sports medicine and GI > than cardiology? pubmed.ncbi.nlm.nih.gov/39661402/

  Ver post
• Iain Bressendorff, MD PhD@ibressendorff.bsky.social19-04-2026 11:34

  Huge fan of spiro, but wouldn’t use it first-line if I didn’t suspect hyperaldosteronism. No CVD outcome data and the side effects for men are not trivial. Don’t feel that the modest effect on BP in primary HTN justifies its use over A/C/D.

  Ver post

Inicia sesión para ver más

Cuentas que bloquea

En Bluesky los bloqueos son registros públicos.

Esta cuenta no bloquea a nadie.